• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Thursday, October 31, 2019

    Offline Date

    Thursday, April 30, 2020

    ACPE Expiration Date

    Monday, October 31, 2022

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      This presentation will distinguish between reference biologics and biosimilars. It will discuss the analytical data needed to establish biosimilarity.   It will define the scientific process of extrapolation and dispel some of the statements and misconceptions made concerning biosimilars.  The program will review the currently FDA approved oncology biosimilars and those that are commercially available.  It will also take an in-depth look at the oncology biosimilar pipeline and what products to expect in the coming year.
       

      Handouts

      • Slide Document :   ce_5_slides.pdf

      Financial Support By

      joint funding from Advanced Accelerator Applications, a Novartis Company, BMS and Pfizer Alliance, Celgene Corporation, Coherus Biosciences, Merck & Co., Inc., and Pfizer
    • Pharmacist

      Describe the types of therapeutic data needed to establish effectiveness in curative diseases.
      Describe what misconceptions exist with the term ‘highly similar’ used to describe a biosimilar
      List the oncology agents that are currently commercially available, and what’s the potential timeline for those not available
      Identify the totality of evidence necessary to establish extrapolated indications

      Nurse

      Describe what misconceptions exist with the term ‘highly similar’ used to describe a biosimilar
      Describe the types of therapeutic data needed to establish effectiveness in curative diseases.
      Identify the totality of evidence necessary to establish extrapolated indications
      List the oncology agents that are currently commercially available, and what’s the potential timeline for those not available
    • Activity Type

      Knowledge

      CE Broker

      20-747284

      Universal Activity Number

      Pharmacist 0798-0000-19-189-H01-P
      Nurse 0798-0000-19-189-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Jim  Koeller, MS
      Professor of Pharmacy, Medicine & Oncology, University of Texas at Austin and the Health Science Center

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).